CORONA Remedies to Meet Investors on June 8-9, 2026 in Singapore
CORONA Remedies Limited officials will participate in investor meetings organized by IIFL Capital on June 8-9, 2026, in Singapore. Discussions will be limited to publicly available information.
This is a routine investor relations activity (Non-Deal Roadshow) where only publicly available information will be discussed. It does not involve any new deal, financial results, or strategic changes that would significantly impact the company's stock or operations.
The announcement is a routine disclosure about upcoming investor meetings and does not contain any specific financial or business performance updates that would indicate a positive or negative sentiment. It's a standard communication.
CORONA Remedies Limited announced that its officials will participate in a Non-Deal Roadshow (NDR) to meet investors. The meetings are scheduled to take place on June 08, 2026, and June 09, 2026, starting from 09:00 A.M. (SST) onwards.
These meetings are organized by IIFL Capital and will be conducted as 1x1 meetings in Singapore. The discussions during these sessions will be based solely on publicly available information, and no unpublished price sensitive information (UPSI) will be shared. The company has also noted that the schedule may be subject to change due to unforeseen circumstances.
This intimation is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement is also available on the company's website, www.coronaremedies.com.
What to do with a filing like this
CORONA Remedies Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by CORONA Remedies Limited. Read the original for the full detail.